Analyst Price Targets — HOLX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 21, 2025 10:08 am | — | BNP Paribas | $79.00 | $74.12 | TheFly | Hologic downgraded to Neutral from Outperform at BNP Paribas Exane |
| October 23, 2025 9:49 am | — | Mizuho Securities | $78.00 | $73.93 | TheFly | Hologic downgraded to Neutral from Outperform at Mizuho |
| October 22, 2025 1:31 pm | — | Stephens | $76.00 | $74.01 | TheFly | Hologic downgraded to Equal Weight from Overweight at Stephens |
| October 21, 2025 5:37 pm | — | Leerink Partners | $78.00 | $74.08 | TheFly | Hologic price target raised to $78 from $70 at Leerink |
| October 7, 2025 10:10 am | Vijay Kumar | Evercore ISI | $78.00 | $67.34 | TheFly | Hologic upgraded to Outperform from In Line at Evercore ISI |
| July 31, 2025 11:15 am | — | Mizuho Securities | $75.00 | $64.98 | TheFly | Hologic price target raised to $75 from $70 at Mizuho |
| May 5, 2025 11:25 am | Tejas Savant | Morgan Stanley | $65.00 | $52.73 | TheFly | Hologic price target lowered to $65 from $77 at Morgan Stanley |
| November 5, 2024 11:39 am | Anthony Petrone | Mizuho Securities | $87.00 | $78.80 | StreetInsider | Hologic (HOLX) PT Lowered to $87 at Mizuho |
| October 4, 2024 9:15 am | Anthony Petrone | Mizuho Securities | $90.00 | $79.63 | TheFly | Hologic price target raised to $90 from $85 at Mizuho |
| October 1, 2024 6:01 am | Patrick Donnelly | Citigroup | $85.00 | $81.46 | TheFly | Hologic downgraded to Neutral from Buy at Citi |
Latest News for HOLX
Private equity groups Blackstone and TPG are seeking more than $4 billion for medical technology firm Hologic's surgical unit, the Financial Times reported on Thursday, citing people familiar with the matter.
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc., a global leader in women's health, today released its 2025 Sustainability Report. The new report coincides with Hologic's 40th anniversary and underscores how the company's longstanding purpose — to enable healthier lives for women everywhere, every day — continues to drive progress for patients, communities and the planet. “We have always firmly believed that our…
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. today announced a significant and far-reaching victory in the Unified Patent Court (UPC) in Germany, which ruled that Siemens* infringed upon a critical Hologic mammography technology patent in Siemens' latest mammography system. The court imposed a sweeping injunction, immediately prohibiting Siemens from making, offering, placing on the market, using or importing…
BOSTON--(BUSINESS WIRE)--OM1 helped power a 650,000-patient real-world evidence study supporting FDA approval of Hologic's Aptima HPV Assay for cervical cancer screening.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.